HT
Halia Therapeutics, Inc.
SEC filingBiotechnology · Lehi, UT
Amount raised$3.5Msold at filing
Total offering$20M$16.5M still open
Investors in the raise9count reported to the SEC
FiledAug 31, 2026first sale Aug 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Preston B. CampbellDirector
Mary B. BeckerleDirector
David CheckettsDirector
Gary B. SabinDirector
Jeffrey BurtonExecutive Officer
David BearssDirector
John S.K. KauweDirector
Executive officers, directors and promoters as listed on the Form D.